Metraipolis › archive › dc_de76de757079

Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events — Europe PMC PMID:41259313

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41259313
DOI
10.1371/journal.pone.0336767
License (as archived)
solo-consultazione
Archived
2026-10-18T07:04:18.669Z
SHA-256 of the archived text
9b8c900f18c4e7be14646ac40a1c5436bbee5b6906f3ed6c667d8933c4c4534a
Stable URL of this page
https://metraipolis.com/documento/dc_de76de757079

How to cite

Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events — Europe PMC PMID:41259313 — Europe PMC (en), https://europepmc.org/article/MED/41259313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de76de757079 (Metraipolis archive dc_de76de757079, sha256 9b8c900f18c4e7be14646ac40a1c5436bbee5b6906f3ed6c667d8933c4c4534a)
BibTeX
@misc{dcde76de757079,
  title = {Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events — Europe PMC PMID:41259313},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41259313},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de76de757079; sha256 9b8c900f18c4e7be14646ac40a1c5436bbee5b6906f3ed6c667d8933c4c4534a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41259313. Agents can read the archived copy with the MCP tool read_document.